St. Jude Children’s Research Hospital scientists led a study opening up a new window into understanding and potentially interrupting the progression of Alzheimer’s disease using an approach that is producing insight in cancer and other diseases. With the results of...
Neurogenerative Disease
Category
University of Edinburgh Leads MND Platform Trial in the UK
A groundbreaking clinical trial focusing on Motor Neuron Disease (MND) has commenced, enabling patients to participate in more than one treatment at a time. Called MND-SMART, this UK-wide initiative aims to identify treatments that can slow, stop or reverse...
McGill University Translational Neuroimaging Laboratory Identify New Role of Genetic Risk Factor in Alzheimer’s Disease
McGill University, Neuroimaging Translational Laboratory researchers, recently announced that they have uncovered that the apolipoprotein ꜫ4 (APOE ꜫ4) gene is associated with an even greater role in dementia. Background In a recently published study in...
Prominent Couple Give $15 Million to Washington Univ. to Neurodegenerative Disease Test Therapies
A prominent couple (Rodger and Paula Riney) have made a $15 million gift to Washington University of Medicine, St. Louis. The aim of the money is to accelerate research and development for Alzheimer’s disease and Parkinson’s disease. Rodger Rines sold his brokerage...
Kainos Medicine to Launch Clinical Trial to Target Multiple System Atrophy
As reported in Korea Biomedical Review by Lee Han-Soo, Kainos Medicine plans on launching clinical trials testing its KM-819 on multiple system atrophy (MSA) patients. Also known as Shy-Drager syndrome, it is a rare degenerative brain disease characterized by symptoms...
Researchers Detail How Neurodegeneration-Related Proteins Enter Cells
As announced in Eureakalert!, UT Southwestern Medical Center researchers have published some recent findings in Journal of Biological Chemistry: detailing how human “cells invite inside corrupted proteins that can turn normal proteins corrupt, leading to...